<DOC>
	<DOCNO>NCT01149330</DOCNO>
	<brief_summary>The purpose study demonstrate efficacy Adapalene 0.1 % /Benzoyl Peroxide 2.5 % Gel treatment acne vulgaris . The safety also evaluate .</brief_summary>
	<brief_title>Evaluation Efficacy Safety Adapalene 0.1 % /Benzoyl Peroxide 2.5 % Gel Treatment Acne Vulgaris</brief_title>
	<detailed_description />
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Adapalene</mesh_term>
	<mesh_term>Benzoyl Peroxide</mesh_term>
	<criteria>Male female Subjects , age 12 35 year inclusive , moderate severe facial acne vulgaris ( describe scale score 3 4 ) , Subjects minimum 20 maximum 50 Inflammatory Lesions ( papule pustule ) face , exclude nose , Subjects minimum 30 maximum 100 NonInflammatory Lesions ( open comedo close comedo ) face , exclude nose , Female Subjects childbearing potential negative urine pregnancy test Baseline visit must practice highly effective method contraception study : oral/systemic [ injectable , patchâ€¦ ] contraception ( must stable dose 3 month prior study entry ) , Intrauterine Device , strict abstinence , condom , diaphragm , sponge , spermicides partner vasectomy , Females nonchildbearing potential , i.e. , premenses , postmenopausal ( absence menstrual bleeding 2 year ) , hysterectomy , bilateral tubal ligation , bilateral ovariectomy , secondary infertility sterility require UPT begin study , Subjects read sign approve Informed Consent form prior participation study . Subjects majority must sign assenttoparticipate form participate study must one parent guardian read sign Informed Consent form prior study related procedure , Subjects willing capable cooperate extend degree require protocol . Subjects participate another investigational drug device research study within 30 day enrollment , Female Subjects pregnant , nurse plan pregnancy study , Subjects 1 nodule cyst face Subjects acne conglobata , acne fulminans , secondary acne ( chloracne , druginduced acne , etc . ) , Subjects know suspect allergy one investigational product ( see package insert and/or investigator brochure ) , Subjects pathological condition photosensitive porphyria , SLE , LED , solar polymorphous eruption , actinic prurigo , solar urticaria , etc . Subjects beard facial hair might interfere study assessment , Subjects foresee intensive UV exposure study ( mountain sport , UV radiation , sunbathe , etc ... ) Female subject history hormonal change . Subjects skin condition disease require topical systemic therapy , interfere investigational product may directly affect evaluation criterion : Topical treatment acne past two week . Antiinflammatory topic last two week . Use topical corticosteroid face last four week . Antiinflammatory systemic ( hormonal ) last four week . Use systemic corticosteroid last four week . Systemic antibiotic last four week ( exclude penicillin ) . Systemic retinoids last six month . Other systemic antiacne last four week . Anticonceptional oral use exclusively control acne past six month . Cosmetic procedure facial , peel , exfoliation , extraction comedo , application LED , laser pulse light last two week . Cosmetic procedure PDT last four week .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Adapalene</keyword>
	<keyword>Benzoyl Peroxide</keyword>
	<keyword>Acne Vulgaris</keyword>
</DOC>